caseSensitivecompositionalcontentcopyrightdatedescriptionexperimentalhierarchyMeaningjurisdictionnamepublisherpurposestatustitleurlversion- Values Differ
versionNeeded| Error | CodeSystem.version | Values for version differ: '3.0.0' vs '2.0.0' |
| Warning | CodeSystem.property.where(code='status').uri | Changed value for uri: 'http://hl7.org/fhir/concept-properties#status' vs 'http://terminology.hl7.org/CodeSystem/utg-concept-properties#status' |
| Warning | CodeSystem.property.where(code='status').description | Changed value for description: 'A code that indicates the status of the concept' vs 'Status of the concept' |
| Name | Value | Comments | |
|---|---|---|---|
| caseSensitive | true | ||
| compositional | false | ||
| content | complete | ||
| copyright | This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html | ||
| date | 2019-12-01 | ||
| description | HL7-defined code system of concepts which specify a type of tissue removed from a patient during a procedure. Used in HL7 Version 2 messaging in the PR1 segment. | ||
| experimental | false | ||
| hierarchyMeaning | is-a | ||
| jurisdiction | |||
| name | TissueType | ||
| publisher | Health Level Seven International | ||
| purpose | Underlying Master Code System for V2 table 0417 (Tissue Type Code) | ||
| status | active | ||
| title | tissueType | ||
| url | http://terminology.hl7.org/CodeSystem/v2-0417 | ||
| version | 3.0.0 | 2.0.0 |
|
| versionNeeded | false | ||
| Code | Display | status | v2-table-deprecated | status | v2-table-deprecated | deprecated | Comments | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Insufficient Tissue | active | A | active | A | ||||||||
| 2 | Not abnormal | active | A | active | A | ||||||||
| 3 | Abnormal-not categorized | active | A | active | A | ||||||||
| 4 | Mechanical abnormal | active | A | active | A | ||||||||
| 5 | Growth alteration | active | A | active | A | ||||||||
| 6 | Degeneration & necrosis | active | A | active | A | ||||||||
| 7 | Non-acute inflammation | active | A | active | A | ||||||||
| 8 | Non-malignant neoplasm | active | A | active | A | ||||||||
| 9 | Malignant neoplasm | active | A | active | A | ||||||||
| 0 | No tissue expected | active | A | active | A | ||||||||
| B | Basal cell carcinoma | active | A | active | A | ||||||||
| C | Carcinoma-unspecified type | active | A | active | A | ||||||||
| G | Additional tissue required | active | A | active | A | ||||||||